Is Tobacco smoke (mainstream) safe for babies and kids?

Infants are more vulnerable to Tobacco smoke (mainstream) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

Maternal cigarette smoking during pregnancy is one of the most consistently documented preventable causes of adverse perinatal outcomes. Active smoking causes: (1) intrauterine growth restriction (IUGR) — reducing birth weight by an average of 200–250g at term; (2) increased preterm birth risk (~2× elevated in smokers); (3) placental abruption and placenta previa (2–3× elevated risk); (4) increased risk of ectopic pregnancy; (5) SIDS — smoking during pregnancy is the single largest identifiable risk factor for SIDS (2–3× elevated risk); (6) stillbirth (relative risk ~1.3–1.5×). Carbon monoxide in tobacco smoke crosses the placenta and binds fetal hemoglobin with higher affinity than maternal hemoglobin, causing fetal hypoxia — a key mechanism for growth restriction and SIDS risk. Nicotine crosses the placenta and has adverse effects on fetal brain development. Nitrosamines (NNK, NNN) are transplacentally transferred and have caused lung and pancreatic cancer in offspring of exposed animals. Even SHS exposure during pregnancy carries measurable fetal risk (IUGR, preterm birth). Cessation at any point in pregnancy reduces risk — cessation before 15 weeks largely normalizes SIDS and prematurity risk.